2MLM

Solution structure of sortase A from S. aureus in complex with benzo[d]isothiazol-3-one based inhibitor

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.6 mM [U-100% 13C; U-100% 15N] sortase A-1, 2.4 mM N-(adamantan-1-yl)-2-(3-oxo-2,3-dihydro-1,2-benzothiazol-2-yl)-acetamide-2, 5.0 % [U-100% 2H] D2O-3, 2.4 % [U-100% 2H] DMSO-4, 20 mM [U-100% 2H] sodium acetate-5, 50 mM sodium chloride-6, 10 mM calcium chloride-7	95% H2O/5% D2O	0.1	6.0	ambient	298
2	3D HNCA	1.6 mM [U-100% 13C; U-100% 15N] sortase A-1, 2.4 mM N-(adamantan-1-yl)-2-(3-oxo-2,3-dihydro-1,2-benzothiazol-2-yl)-acetamide-2, 5.0 % [U-100% 2H] D2O-3, 2.4 % [U-100% 2H] DMSO-4, 20 mM [U-100% 2H] sodium acetate-5, 50 mM sodium chloride-6, 10 mM calcium chloride-7	95% H2O/5% D2O	0.1	6.0	ambient	298
3	3D CBCA(CO)NH	1.6 mM [U-100% 13C; U-100% 15N] sortase A-1, 2.4 mM N-(adamantan-1-yl)-2-(3-oxo-2,3-dihydro-1,2-benzothiazol-2-yl)-acetamide-2, 5.0 % [U-100% 2H] D2O-3, 2.4 % [U-100% 2H] DMSO-4, 20 mM [U-100% 2H] sodium acetate-5, 50 mM sodium chloride-6, 10 mM calcium chloride-7	95% H2O/5% D2O	0.1	6.0	ambient	298
4	3D 1H-15N NOESY	1.6 mM [U-100% 13C; U-100% 15N] sortase A-1, 2.4 mM N-(adamantan-1-yl)-2-(3-oxo-2,3-dihydro-1,2-benzothiazol-2-yl)-acetamide-2, 5.0 % [U-100% 2H] D2O-3, 2.4 % [U-100% 2H] DMSO-4, 20 mM [U-100% 2H] sodium acetate-5, 50 mM sodium chloride-6, 10 mM calcium chloride-7	95% H2O/5% D2O	0.1	6.0	ambient	298
5	3D 1H-13C NOESY aliphatic	1.6 mM [U-100% 13C; U-100% 15N] sortase A-1, 2.4 mM N-(adamantan-1-yl)-2-(3-oxo-2,3-dihydro-1,2-benzothiazol-2-yl)-acetamide-2, 5.0 % [U-100% 2H] D2O-3, 2.4 % [U-100% 2H] DMSO-4, 20 mM [U-100% 2H] sodium acetate-5, 50 mM sodium chloride-6, 10 mM calcium chloride-7	95% H2O/5% D2O	0.1	6.0	ambient	298
6	3D 1H-13C NOESY aromatic	1.6 mM [U-100% 13C; U-100% 15N] sortase A-1, 2.4 mM N-(adamantan-1-yl)-2-(3-oxo-2,3-dihydro-1,2-benzothiazol-2-yl)-acetamide-2, 5.0 % [U-100% 2H] D2O-3, 2.4 % [U-100% 2H] DMSO-4, 20 mM [U-100% 2H] sodium acetate-5, 50 mM sodium chloride-6, 10 mM calcium chloride-7	95% H2O/5% D2O	0.1	6.0	ambient	298
7	3D (F1)-15N,13C-filtered 1H-13C NOESY aliphatic	1.6 mM [U-100% 13C; U-100% 15N] sortase A-1, 2.4 mM N-(adamantan-1-yl)-2-(3-oxo-2,3-dihydro-1,2-benzothiazol-2-yl)-acetamide-2, 5.0 % [U-100% 2H] D2O-3, 2.4 % [U-100% 2H] DMSO-4, 20 mM [U-100% 2H] sodium acetate-5, 50 mM sodium chloride-6, 10 mM calcium chloride-7	95% H2O/5% D2O	0.1	6.0	ambient	298
8	2D (F1,F2)-13C,15N-filtered NOESY	1.6 mM [U-100% 13C; U-100% 15N] sortase A-1, 2.4 mM N-(adamantan-1-yl)-2-(3-oxo-2,3-dihydro-1,2-benzothiazol-2-yl)-acetamide-2, 5.0 % [U-100% 2H] D2O-3, 2.4 % [U-100% 2H] DMSO-4, 20 mM [U-100% 2H] sodium acetate-5, 50 mM sodium chloride-6, 10 mM calcium chloride-7	95% H2O/5% D2O	0.1	6.0	ambient	298
9	2D (F1,F2)-13C,15N-filtered TOCSY	1.6 mM [U-100% 13C; U-100% 15N] sortase A-1, 2.4 mM N-(adamantan-1-yl)-2-(3-oxo-2,3-dihydro-1,2-benzothiazol-2-yl)-acetamide-2, 5.0 % [U-100% 2H] D2O-3, 2.4 % [U-100% 2H] DMSO-4, 20 mM [U-100% 2H] sodium acetate-5, 50 mM sodium chloride-6, 10 mM calcium chloride-7	95% H2O/5% D2O	0.1	6.0	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600

NMR Refinement
Method	Details	Software
torsion angle dynamics, simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS	1.2	Brunger, Adams, Clore, Gros, Nilges and Read
2	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
3	data analysis	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
4	processing	TOPSPIN	3.2	Bruker Biospin
5	collection	VNMRJ	2.1b	Varian
6	chemical shift assignment	CARA	1.9.0	R. Keller
7	structure solution	UNIO	2.0.2	T. Herrmann, F. Fiorito, J. Volk
8	peak picking	UNIO	2.0.2	T. Herrmann, F. Fiorito, J. Volk
9	data analysis	UNIO	2.0.2	T. Herrmann, F. Fiorito, J. Volk
10	refinement	CYANA	2.1	Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.